Wed, Nov 02, 2022
Sun Pharma share price: Post second quarter results, brokerages have revised the target price on the stock
More >
Mon, Oct 31, 2022
As per Zee Business estimates, the company’s revenue may come at Rs 10,808 crore, and profit after tax at Rs 1.964.7 crore, while EBITDA is likely to be at Rs 2781.7 crore and, margins around 25.7 per cent in Q2.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.